- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2399-3642
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Target expression is a relevant factor in synthetic lethal screens ; volume:5 ; number:1 ; day:19 ; month:8 ; year:2022 ; pages:1-2 ; date:12.2022
Communications biology ; 5, Heft 1 (19.8.2022), 1-2, 12.2022
- Creator
-
Schultz, Iman J.
Coelingh Bennink, Herjan J. T.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s42003-022-03746-6
- URN
-
urn:nbn:de:101:1-2022110718094023144324
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schultz, Iman J.
- Coelingh Bennink, Herjan J. T.
- SpringerLink (Online service)
Other Objects (12)
Reply to: Target expression is a relevant factor in synthetic lethal screens
Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens
Detection of KRAS Synthetic Lethal Partners through Integration of Existing RNAi Screens
A synthetic lethal strategy to target chromosome 8p deleted cancers
Synthetic Lethal Screen Identifies NF-κB as a Target for Combination Therapy with Topotecan for patients with Neuroblastoma
Human synthetic lethal inference as potential anti-cancer target gene detection
Mitoferrin2 is a synthetic lethal target for chromosome 8p deleted cancers
CDK12 is hyperactivated and a synthetic-lethal target in BRAF-mutated melanoma
Kinome‐Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma
INPP5A phosphatase is a synthetic lethal target in GNAQ and GNA11-mutant melanomas
Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer
A synthetic lethal screen identifies ATR-inhibition as a novel therapeutic approach for POLD1-deficient cancers
Reply to: Target expression is a relevant factor in synthetic lethal screens
Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens
Detection of KRAS Synthetic Lethal Partners through Integration of Existing RNAi Screens
A synthetic lethal strategy to target chromosome 8p deleted cancers
Synthetic Lethal Screen Identifies NF-κB as a Target for Combination Therapy with Topotecan for patients with Neuroblastoma
Human synthetic lethal inference as potential anti-cancer target gene detection
Mitoferrin2 is a synthetic lethal target for chromosome 8p deleted cancers
CDK12 is hyperactivated and a synthetic-lethal target in BRAF-mutated melanoma
Kinome‐Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma
INPP5A phosphatase is a synthetic lethal target in GNAQ and GNA11-mutant melanomas
Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer
A synthetic lethal screen identifies ATR-inhibition as a novel therapeutic approach for POLD1-deficient cancers
Reply to: Target expression is a relevant factor in synthetic lethal screens
Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens
Detection of KRAS Synthetic Lethal Partners through Integration of Existing RNAi Screens
A synthetic lethal strategy to target chromosome 8p deleted cancers
Synthetic Lethal Screen Identifies NF-κB as a Target for Combination Therapy with Topotecan for patients with Neuroblastoma
Human synthetic lethal inference as potential anti-cancer target gene detection
Mitoferrin2 is a synthetic lethal target for chromosome 8p deleted cancers
CDK12 is hyperactivated and a synthetic-lethal target in BRAF-mutated melanoma
Kinome‐Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma
INPP5A phosphatase is a synthetic lethal target in GNAQ and GNA11-mutant melanomas
Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer